Mereo BioPharma Group PLC ADR (MREO) Ownership

0.96 ↑0.02 (2.07%)
As of February 7, 2023, 10:01am EST.

Institutional Ownership

Orbimed Advisors, LLC is the biggest individual institutional holder of Mereo BioPharma Group PLC ADR (MREO), owning a total of 10.6 million shares. Combined, the top 22 institutional holders of MREO own 53.39% of the company with a total of 66.7 million shares.

In the latest ownership report on September 30th 2022, the top 22 institutional holders decreased their combined ownership of MREO by 4.5 million shares. 9 institutions bought 3,877,905 total additional shares and increased their ownership by an average of 42.96%. However 6 institutions sold 8,408,324 total shares and decreased their ownership by an average of 10.96%.

Overall this is a negative sign as the number of shares owned by the top 20 institutional holders of Mereo BioPharma Group PLC ADR decreased by a net total of -4,530,419 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Orbimed Advisors, LLC8.485%9.207%10,605,522894,1002022-09-30
Rubric Capital Management LP8.294%-38.135%10,366,120-6,390,0002022-09-30
Point72 Asset Management, L.P.7.864%-2.059%9,829,354-206,6162022-09-30
Suvretta Capital Management, LLC5.892%-19.445%7,364,438-1,777,6292022-09-30
Rock Springs Capital Management LP4.997%0.235%6,244,89714,6222022-09-30
Clearline Capital LP3.166%29.378%3,957,135898,5392022-09-30
Citadel Advisors Llc2.461%11.307%3,075,887312,4622022-09-30
Boxer Capital LLC1.800%0.000%2,250,00002022-09-30
Alkeon Capital Management, LLC1.709%23.047%2,135,600400,0002022-09-30
Tekla Capital Management LLC1.241%0.000%1,551,08202022-09-30
Artal Group S A1.200%0.000%1,500,00002022-09-30
Millennium Management LLC1.003%78.604%1,253,611551,7152022-09-30
Renaissance Technologies Corp0.987%102.594%1,233,614624,7052022-09-30
Dafna Capital Management LLC0.877%0.000%1,096,51302022-09-30
Octagon Capital Advisors LP0.800%0.000%1,000,00002022-09-30
Goldman Sachs Group Inc0.567%-1.161%709,126-8,3292022-09-30
BlackRock Inc0.526%-2.788%657,182-18,8502022-09-30
PRIMECAP Management Company0.252%-2.145%314,760-6,9002022-09-30
J. Goldman & Co LP0.248%130.000%310,500175,5002022-09-30
Formidable Asset Management LLC0.226%2.273%281,8186,2622022-09-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Orbimed Advisors, LLC8.485%9.207%10,605,522894,1002022-09-30
Rubric Capital Management LP8.294%-38.135%10,366,120-6,390,0002022-09-30
Point72 Asset Management, L.P.7.864%-2.059%9,829,354-206,6162022-09-30
Suvretta Capital Management, LLC5.892%-19.445%7,364,438-1,777,6292022-09-30
Rock Springs Capital Management LP4.997%0.235%6,244,89714,6222022-09-30
Clearline Capital LP3.166%29.378%3,957,135898,5392022-09-30
Citadel Advisors Llc2.461%11.307%3,075,887312,4622022-09-30
Boxer Capital LLC1.800%0.000%2,250,00002022-09-30
Alkeon Capital Management, LLC1.709%23.047%2,135,600400,0002022-09-30
Tekla Capital Management LLC1.241%0.000%1,551,08202022-09-30
Artal Group S A1.200%0.000%1,500,00002022-09-30
Millennium Management LLC1.003%78.604%1,253,611551,7152022-09-30
Renaissance Technologies Corp0.987%102.594%1,233,614624,7052022-09-30
Dafna Capital Management LLC0.877%0.000%1,096,51302022-09-30
Octagon Capital Advisors LP0.800%0.000%1,000,00002022-09-30
Schonfeld Strategic Advisors LLC0.573%-18.590%715,696-163,4272022-06-30
Goldman Sachs Group Inc0.567%-1.161%709,126-8,3292022-09-30
BlackRock Inc0.526%-2.788%657,182-18,8502022-09-30
PRIMECAP Management Company0.252%-2.145%314,760-6,9002022-09-30
J. Goldman & Co LP0.248%130.000%310,500175,5002022-09-30
Formidable Asset Management LLC0.226%2.273%281,8186,2622022-09-30
Toroso Investments LLC0.221%0.000%275,556275,5562022-06-30

Mutual Fund Ownership

MEDICAL BioHealth EUR Acc is the biggest individual fund holder of Mereo BioPharma Group PLC ADR (MREO), owning a total of 2 million shares. Combined, the top 20 mutual fund holders of MREO own 4.96% of the company with a total of 6.2 million shares.

In the latest ownership report on December 31st 2022, the top 20 fund holders decreased their combined ownership of MREO by 7 thousand shares. None of the mutual funds bought any additional shares. However 1 funds sold 7,200 total shares and decreased their ownership by an average of 31.58%.

Overall this is a negative sign as the number of shares owned by the top 20 mutual funds holding Mereo BioPharma Group PLC ADR decreased by a net total of -7,200 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
apo Medical Opportunities Institutionell0.040%0.000%49,45902022-12-31
PMC Diversified Equity0.030%0.000%37,36702022-12-31
Forefront Tiresias Strategy0.013%-31.579%15,600-7,2002022-12-31
NT Quality Small Cap Core0.001%0.000%61902022-12-31
NT Quality SCC US Fund - L0.001%0.000%61902022-12-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
MEDICAL BioHealth EUR Acc1.636%0.000%2,045,32702022-09-30
Tekla Healthcare Investors0.851%0.000%1,063,79902022-06-30
iShares Biotechnology ETF0.507%-0.153%633,297-9702022-11-30
APO Medical Opportunities R0.490%0.000%611,77202022-11-30
Tekla Life Sciences Investors0.390%0.000%487,28302022-06-30
Formidable ETF0.251%8.695%313,12825,0482022-12-30
RIM Global Bioscience EUR0.248%0.000%309,71002022-09-30
PRIMECAP Odyssey Aggressive Growth0.177%0.000%221,06002022-09-30
VariopartnerSICAV-SectHlthcr Opps P$Acc0.128%0.000%160,00002022-07-31
Fidelity® NASDAQ Composite Index®0.077%0.000%96,63002022-11-30
Vanguard US Opportunities Ins USD Acc0.073%-7.158%90,800-7,0002022-10-31
iShares Nasdaq US Biotech ETF USD Acc0.040%4.318%49,6202,0542022-11-30
apo Medical Opportunities Institutionell0.040%0.000%49,45902022-12-31
PMC Diversified Equity0.030%0.000%37,36702022-12-31
Forefront Tiresias Strategy0.013%-31.579%15,600-7,2002022-12-31
ProShares Ultra Nasdaq Biotechnology0.008%8.135%9,8107382022-07-31
GF NASDAQ Bio-Tech Idx QDII RMB A0.002%136.646%2,7381,5812022-06-30
Invesco Nasdaq Biotechnology ETF0.002%0.000%2,16902022-11-30
NT Quality Small Cap Core0.001%0.000%61902022-12-31
NT Quality SCC US Fund - L0.001%0.000%61902022-12-31

Discussions

Please log in or register to share your thoughts.

chickenEggs

$MREO HODLing
and buying more when I can.

0 Like Report
rikutarii3

$MREO Waiting waiting waiting — you know for what !!! Announcement!!!

0 Like Report
mezzymez2

$MREO I still don’t wanna buy it

0 Like Report
chainstrader249

$MREO Ahhhhhhh payday tomorrow. Know what I’m doing with some spare

0 Like Report